Pulmonary Tuberculosis
98
11
15
58
Key Insights
Highlights
Success Rate
97% trial completion (above average)
Published Results
20 trials with published results (20%)
Research Maturity
58 completed trials (59% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
2.0%
2 terminated out of 98 trials
96.7%
+10.1% vs benchmark
22%
22 trials in Phase 3/4
34%
20 of 58 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 58 completed trials
Clinical Trials (98)
TBTC Study 29: Rifapentine During Intensive Phase Tuberculosis (TB) Treatment
Trial of Novel Regimens for the Treatment of Pulmonary Tuberculosis
Effectiveness of Psychosocial Counseling in Patients With a New Tuberculosis Diagnosis
Phase 2 Trial Assessing TBAJ876 or Bedaquiline, With Pretomanid and Linezolid in Adults With Drug-sensitive Pulmonary Tuberculosis
Artificial Intelligence-driven Tuberculosis Landscape Analysis & Stratification Research
Efficacy and Safety Evaluation of Two to Four Months of Treatment With the Combination Regimens of DBOS and PBOS in Adults With Pulmonary Tuberculosis
Virtual Reality Cave vs. Simulated Home for Community Nursing Education: A Crossover Trial Comparing Student Competence, Confidence, and Satisfaction
A Study of Quabodepistat-containing Regimens for the Treatment of Drug-resistant Pulmonary Tuberculosis
Safety and Tolerability of Metformin in People With Tuberculosis (TB) and Human Immunodeficiency Virus (HIV)
AIPH-TB: AI-Optimised Pyrazinamide-Hydroxychloroquine vs Standard RIPE for Drug-Sensitive Pulmonary Tuberculosis - A Phase II RCT
Innovating Shorter, All- Oral, Precised Treatment Regimen for Rifampicin Resistant Tuberculosis：BLMZ Chinese Cohort
A PAN-USR TB Multi-Center Trial
PanACEA - STEP2C -01
Platform Assessing Regimens and Durations In a Global Multisite Consortium for TB
ATORvastatin in Pulmonary TUBerculosis
Diagnostic Accuracy of CAD4TB and C-reactive Protein Assay as Triage Tests for Pulmonary Tuberculosis
I-FALMIN Albumin Supplement for Patients With Pulmonary Tuberculosis
PanACEA DElpazolid Dose-finding and COmbination DEvelopment (DECODE)
A Phase 3 Trial Assessing Safety and Efficacy of B-Pa-L in Participants With DR-TB
Innovating Shorter, All- Oral, Precised Treatment Regimen for Rifampicin Resistant Tuberculosis：BDLL Chinese Cohort